Search
Close this search box.
Home » Base Editing: A Strong Contender in Cell and Gene Therapy
gen-therapy

Base Editing: A Strong Contender in Cell and Gene Therapy

what you read
Rate this post

Base editors, DNA double-strand break (DSB)-independent genome modification agents, have been recognized alongside prime editors as key technologies to watch this year,1 and advances to date have been encouraging. Although these technologies have yet to enter the clinic, the first candidate therapy received investigational new drug approval from the U.S. Food and Drug Administration in 2021—less than five years after the first base editor was described.2

logo p7 medicine

p7 medicine

P7 Medicine ( P7MEDICINE) was founded by people who believe that everyone can make choices about health and life changes that face us during our lives.

Leave a Reply

Your email address will not be published. Required fields are marked *